The Technical Analyst
Universe Pharmaceuticals [UPC]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Universe Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals
12.82% $2.20
America/New_York / 23 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 8.02 mill |
| EPS: | -1.700 |
| P/E: | -1.290 |
| Earnings Date: | Apr 30, 2024 |
| SharesOutstanding: | 3.65 mill |
| Avg Daily Volume: | 0.0986 mill |
| RATING 2024-04-23 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/21 | 3/21 | 1/22 | 3/22 | 1/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.290 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.03x |
| Company: PE -1.290 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.927 - 2.47 ( +/- 12.41%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2004-12-31 | Harton Lynn | Buy | 0 | |
| 2004-12-31 | Henriques Adolfo | Buy | 0 | Common Stock |
| 2004-12-31 | Henriques Adolfo | Buy | 0 | Common Stock |
| 2004-12-31 | Moore Jackson W | Buy | 0 | |
| 2004-12-31 | Poynter Lou Ann | Sell | 0 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 77 transactions |
| Buy: 1 159 266 | Sell: 963 935 |
Forecast:
16:00 - $2.19
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $2.19
Forecast 2: 16:00 - $2.19
Forecast 3: 16:00 - $2.19
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.20 (12.82% ) |
| Volume | 0.0522 mill |
| Avg. Vol. | 0.0986 mill |
| % of Avg. Vol | 53.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For UPC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
UPC
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Last 10 Buy Signals
Latest Press Releases
2024-01-30 16:30:00 - Press Release
Universe Pharmaceuticals Inc Reports Fiscal Year 2023 Financial Results
Ji'an, china, jan. 30, 2024 /prnewswire/ -- universe pharmaceuticals inc ("universe pharmaceuticals" or the "company") (nasdaq: upc), a pharmaceutical producer and distributor in china, today announced its financial results for the fiscal year ended september 30, 2023. mr. gang lai, chairman and chief executive officer of universe pharmaceuticals, commented, "despite market fluctuations and the economic slowdown impacting our business in fiscal year 2023, we continued our efforts to deliver high quality products to our loyal customers.
2023-08-04 08:30:00 - Press Release
Universe Pharmaceuticals Inc Announces Receipt Of Nasdaq Notification Regarding Minimum Market Value Of Publicly Held Shares
Jiangxi, china, aug. 04, 2023 (globe newswire) -- universe pharmaceuticals inc (nasdaq: upc) (“universe pharmaceuticals” or the “company”), a pharmaceutical producer and distributor in china, today announced that the company received a written notification (the “notification letter”) from the nasdaq stock market llc (“nasdaq”) on august 1, 2023, notifying the company that it is not in compliance with the minimum market value of publicly held shares (“mvphs”) requirement set forth in the nasdaq listing rules for continued listing on the nasdaq global market.
2023-07-27 10:15:00 - Press Release
Universe Pharmaceuticals Inc Announces Share Consolidation
Jiangxi, china, july 27, 2023 (globe newswire) -- universe pharmaceuticals inc (nasdaq: upc) (“universe pharmaceuticals” or the “company”), a pharmaceutical producer and distributor in china, today announced that the company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the company's issued and unissued share capital into one (1) ordinary share with par value of us$0.01875 (the “share consolidation”). as a result of the share consolidation, each six (6) pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
2021-07-30 08:00:00 - Press Release
Universe Pharmaceuticals Inc To Announce Unaudited Financial Results For The First Six Months Of Fiscal Year 2021 On August 2, 2021
Ji'an, jiangxi, china, july 30, 2021 (globe newswire) -- universe pharmaceuticals inc (the “company”) (nasdaq: upc), a pharmaceutical producer and distributor in china, today announced that it will release its unaudited financial results for the first six months of fiscal year 2021 ended march 31, 2021 on monday, august 2, 2021 before the market opens. the company intends to file its financial results on form 6-k with the securities and exchange commission and release its earnings press release accordingly.
2021-03-31 16:15:00 - Press Release
Universe Pharmaceuticals Inc Announces Full Exercise Of Underwriter's Over-allotment Option In The Public Offering
Ji'an, jiangxi, china, march 31, 2021 (globe newswire) -- universe pharmaceuticals inc (the “company”) (nasdaq: upc), a pharmaceutical producer and distributor in china, today announced the underwriter of its previously announced initial public offering of ordinary shares (the "offering") has exercised in full its option to purchase an additional 750,000 ordinary shares at the public offering price of $5.00 per share to cover overallotments, resulting in additional gross proceeds of $3.75 million. after giving effect to the full exercise of the over-allotment option, the total number of shares sold by the company in the offering increased to 5.75 million shares and gross proceeds increased to $28...
Latest News
2024-02-20 08:32:36 - InvestorPlace
Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
Universe Pharmaceuticals (NASDAQ: UPC ) stock is falling on Tuesday after the company's shares experienced a rally during the prior day of trading. Shares of UPC closed out Friday up 43.9% without any clear news from the traditional Chinese medicine company.
2021-08-02 10:31:23 - Pulse2
UPC Stock Increases Over 7% Intraday: Why It Happened
The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased by over 7% during intraday trading. This is why it happened.
2021-07-30 08:00:00 - GlobeNewsWire
Universe Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021
Ji'an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that it will release its unaudited financial results for the first six months of fiscal year 2021 ended March 31, 2021 on Monday, August 2, 2021 before the market opens. The Company intends to file its financial results on Form 6-K with the Securities and Exchange Commission and release its earnings press release accordingly.
2021-07-23 08:00:55 - Pulse2
UPC Stock Increases Over 9% Pre-Market: Why It Happened
The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased by over 9% pre-market. This is why it happened.
2021-07-23 01:16:33 - Pulse2
UPC Stock Increased 28.72% After Hours: Details You Should Know
The stock price of Universe Pharmaceuticals Inc (NASDAQ: UPC) increased 28.72% after hours. These are some details you should know.
2021-05-20 09:29:41 - ETF Trends
Sprott Acquires Physical Uranium Fund as Uranium Bear Market Ends
In a move to offer investors access to spot uranium prices, Sprott Asset Management has taken over Uranium Participation Corporation (UPC), a physical uranium fund that trades in Toronto, relaunching it as the Sprott Physical Uranium Trust. The new trust will launch in late Q2 or Q3 of 2021.
2021-04-01 13:06:14 - InvestorPlace
UPC Stock: Why Universe Pharmaceuticals Is Popping Higher Today
Here's why UPC stock is surging today on news that a broker leading the deal exercised its over-allotment option, in a surprising move. The post UPC Stock: Why Universe Pharmaceuticals Is Popping Higher Today appeared first on InvestorPlace.
2021-04-01 10:41:52 - Pulse2
Universe Pharmaceuticals Stock Price Increased Over 80% Intraday: Why It Happened
The stock price of Universe Pharmaceuticals Inc (Nasdaq: UPC) increased by over 80% during intraday trading. This is why it happened.
2021-03-31 16:15:00 - GlobeNewsWire
Universe Pharmaceuticals INC Announces Full Exercise of Underwriter's Over-Allotment Option in the Public Offering
Ji'an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the underwriter of its previously announced initial public offering of ordinary shares (the "Offering") has exercised in full its option to purchase an additional 750,000 ordinary shares at the public offering price of $5.00 per share to cover overallotments, resulting in additional gross proceeds of $3.75 million. After giving effect to the full exercise of the over-allotment option, the total number of shares sold by the Company in the Offering increased to 5.75 million shares and gross proceeds increased to $28...
2021-03-29 13:16:07 - InvestorPlace
Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks
Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks appeared first on InvestorPlace.